The global digital diabetes management market size is estimated at USD 37.89 billion in 2025 and is predicted to reach around USD 171.63 billion by 2034, accelerating at a CAGR of 18.33% from 2025 to 2034. The North America digital diabetes management market size surpassed USD 10.21 billion in 2024 and is expanding at a CAGR of 18.51% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Digital Diabetes Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Digital Diabetes Management Market, by Product
8.1.1. Devices
8.1.1.1. Market Revenue and Forecast
8.1.2. Application
8.1.2.1. Market Revenue and Forecast
8.1.3. Data Management Software & Platforms
8.1.3.1. Market Revenue and Forecast
8.1.4. Services
8.1.4.1. Market Revenue and Forecast
9.1. Digital Diabetes Management Market, by Device Type
9.1.1. Handheld Devices
9.1.1.1. Market Revenue and Forecast
9.1.2. Wearable Devices
9.1.2.1. Market Revenue and Forecast
10.1. Digital Diabetes Management Market, by Patient Type
10.1.1. Type 1
10.1.1.1. Market Revenue and Forecast
10.1.2. Type 2
10.1.2.1. Market Revenue and Forecast
11.1. Digital Diabetes Management Market, by App
11.1.1. Digital Diabetes Management Apps
11.1.1.1. Market Revenue and Forecast
11.1.2. Weight & Diet Management Apps
11.1.2.1. Market Revenue and Forecast
12.1. Digital Diabetes Management Market, by End-Use
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast
12.1.2. Home Settings
12.1.2.1. Market Revenue and Forecast
12.1.3. Diagnostic Centers& Clinics
12.1.3.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product
13.1.2. Market Revenue and Forecast, by Device Type
13.1.3. Market Revenue and Forecast, by Patient Type
13.1.4. Market Revenue and Forecast, by App
13.1.5. Market Revenue and Forecast, by End-Use
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product
13.1.6.2. Market Revenue and Forecast, by Device Type
13.1.6.3. Market Revenue and Forecast, by Patient Type
13.1.6.4. Market Revenue and Forecast, by App
13.1.7. Market Revenue and Forecast, by End-Use
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Product
13.1.8.2. Market Revenue and Forecast, by Device Type
13.1.8.3. Market Revenue and Forecast, by Patient Type
13.1.8.4. Market Revenue and Forecast, by App
13.1.8.5. Market Revenue and Forecast, by End-Use
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product
13.2.2. Market Revenue and Forecast, by Device Type
13.2.3. Market Revenue and Forecast, by Patient Type
13.2.4. Market Revenue and Forecast, by App
13.2.5. Market Revenue and Forecast, by End-Use
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product
13.2.6.2. Market Revenue and Forecast, by Device Type
13.2.6.3. Market Revenue and Forecast, by Patient Type
13.2.7. Market Revenue and Forecast, by App
13.2.8. Market Revenue and Forecast, by End-Use
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product
13.2.9.2. Market Revenue and Forecast, by Device Type
13.2.9.3. Market Revenue and Forecast, by Patient Type
13.2.10. Market Revenue and Forecast, by App
13.2.11. Market Revenue and Forecast, by End-Use
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product
13.2.12.2. Market Revenue and Forecast, by Device Type
13.2.12.3. Market Revenue and Forecast, by Patient Type
13.2.12.4. Market Revenue and Forecast, by App
13.2.13. Market Revenue and Forecast, by End-Use
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product
13.2.14.2. Market Revenue and Forecast, by Device Type
13.2.14.3. Market Revenue and Forecast, by Patient Type
13.2.14.4. Market Revenue and Forecast, by App
13.2.15. Market Revenue and Forecast, by End-Use
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product
13.3.2. Market Revenue and Forecast, by Device Type
13.3.3. Market Revenue and Forecast, by Patient Type
13.3.4. Market Revenue and Forecast, by App
13.3.5. Market Revenue and Forecast, by End-Use
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product
13.3.6.2. Market Revenue and Forecast, by Device Type
13.3.6.3. Market Revenue and Forecast, by Patient Type
13.3.6.4. Market Revenue and Forecast, by App
13.3.7. Market Revenue and Forecast, by End-Use
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product
13.3.8.2. Market Revenue and Forecast, by Device Type
13.3.8.3. Market Revenue and Forecast, by Patient Type
13.3.8.4. Market Revenue and Forecast, by App
13.3.9. Market Revenue and Forecast, by End-Use
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product
13.3.10.2. Market Revenue and Forecast, by Device Type
13.3.10.3. Market Revenue and Forecast, by Patient Type
13.3.10.4. Market Revenue and Forecast, by App
13.3.10.5. Market Revenue and Forecast, by End-Use
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product
13.3.11.2. Market Revenue and Forecast, by Device Type
13.3.11.3. Market Revenue and Forecast, by Patient Type
13.3.11.4. Market Revenue and Forecast, by App
13.3.11.5. Market Revenue and Forecast, by End-Use
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product
13.4.2. Market Revenue and Forecast, by Device Type
13.4.3. Market Revenue and Forecast, by Patient Type
13.4.4. Market Revenue and Forecast, by App
13.4.5. Market Revenue and Forecast, by End-Use
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product
13.4.6.2. Market Revenue and Forecast, by Device Type
13.4.6.3. Market Revenue and Forecast, by Patient Type
13.4.6.4. Market Revenue and Forecast, by App
13.4.7. Market Revenue and Forecast, by End-Use
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product
13.4.8.2. Market Revenue and Forecast, by Device Type
13.4.8.3. Market Revenue and Forecast, by Patient Type
13.4.8.4. Market Revenue and Forecast, by App
13.4.9. Market Revenue and Forecast, by End-Use
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product
13.4.10.2. Market Revenue and Forecast, by Device Type
13.4.10.3. Market Revenue and Forecast, by Patient Type
13.4.10.4. Market Revenue and Forecast, by App
13.4.10.5. Market Revenue and Forecast, by End-Use
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product
13.4.11.2. Market Revenue and Forecast, by Device Type
13.4.11.3. Market Revenue and Forecast, by Patient Type
13.4.11.4. Market Revenue and Forecast, by App
13.4.11.5. Market Revenue and Forecast, by End-Use
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product
13.5.2. Market Revenue and Forecast, by Device Type
13.5.3. Market Revenue and Forecast, by Patient Type
13.5.4. Market Revenue and Forecast, by App
13.5.5. Market Revenue and Forecast, by End-Use
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product
13.5.6.2. Market Revenue and Forecast, by Device Type
13.5.6.3. Market Revenue and Forecast, by Patient Type
13.5.6.4. Market Revenue and Forecast, by App
13.5.7. Market Revenue and Forecast, by End-Use
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product
13.5.8.2. Market Revenue and Forecast, by Device Type
13.5.8.3. Market Revenue and Forecast, by Patient Type
13.5.8.4. Market Revenue and Forecast, by App
13.5.8.5. Market Revenue and Forecast, by End-Use
14.1. Bayer AG
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Medtronic
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Roche Diagnostics
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Dexcom Inc. LifeScan Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. AgaMatrix
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. One Drop
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Abbott Laboratories
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Ascensia Diabetes Care
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. ARKRAY Inc
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. ACON Laboratories
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample